"It's way more important than anything I do on the field. I love what I do on the field, but, I mean, this is what it's really about," Howard said.

引言当癌症的阴霾笼罩，当一次次治疗宣告失败，希望似乎变得遥不可及。对于许多罹患CD30阳性（CD30+）淋巴瘤，特别是霍奇金淋巴瘤（Hodgkin Lymphoma, HL）的患者而言，如果连靶向药物维布妥昔单抗（Brentuximab ...

The Europe platelet rich plasma (PRP) market is on an impressive growth trajectory, projected to reach USD 94.2 million by 2035, up from USD 62.4 million in 2025. With a steady compound annual growth ...

The Saroornagar police cracked the racket with four recipients and four donors in Alakananda Hospital, followed by a series ...

If preclinical findings were translated into the clinic, they could shorten the CAR-T generation lead time from two weeks to ...

Immune response data from FLAMINGO-01 shows positive results in patients with HER2+ breast cancer, suggesting potential for ...

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable ...

Eirik Tjonnfjord is a Senior Consultant (Hematology) at Fürst Medisinsk Laboratorium. In this interview with Adeleke “Mai ...

When Dr. Filippo Milano left his home in Italy to study medicine in Seattle in 2008, it was supposed to be for six months, just long enough to learn how to do bone marrow transplant. Instead, he ...

Teacher Retirement System of Texas raised its position in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 45.2% during the 4th quarter, Holdings Channel reports. The fund owned ...